Prevention and Management of Dermatologic Adverse Events Associated With Tumor Treating Fields in Patients With Glioblastoma

Importance: Tumor Treating Fields (TTFields) are an anti-mitotic treatment approved for treating newly diagnosed and recurrent glioblastoma, and mesothelioma. TTFields in glioblastoma comprise alternating electric fields (200 kHz) delivered continuously, ideally for ≥18 h/day, to the tumor bed via t...

Descripción completa

Detalles Bibliográficos
Autores principales: Lacouture, Mario E., Anadkat, Milan J., Ballo, Matthew T., Iwamoto, Fabio, Jeyapalan, Suriya A., La Rocca, Renato V., Schwartz, Margaret, Serventi, Jennifer N., Glas, Martin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7399624/
https://www.ncbi.nlm.nih.gov/pubmed/32850308
http://dx.doi.org/10.3389/fonc.2020.01045

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7399624/
https://www.ncbi.nlm.nih.gov/pubmed/32850308
http://dx.doi.org/10.3389/fonc.2020.01045

Ejemplares similares